Esther Rajavelu – Biography
Last update: April 13, 2026Executive profile
Esther was Chief Financial Officer at Fulcrum Therapeutics, and Senior Equities Research Analyst, Biotechnology at UBS. Esther Rajavelu joined Spero Therapeutics in 2025.
Esther Rajavelu is currentlyPresident and Chief Executive Officer at Spero Therapeutics - View - Spero Therapeutics org chart
Create your alert
to follow the career of Esther Rajavelu.
Education
Esther Rajavelu has a Master of Business Administration in Healthcare and Finance from University of Pennsylvania - The Wharton School.
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
More about Esther Rajavelu
Selected links
Do you need to know more about Esther Rajavelu? More results.
Participate
Social media
- Esther Rajavelu on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Esther Rajavelu
The colleagues of Esther Rajavelu
Company Colleagues
- At Spero Therapeutics, Esther Rajavelu has 10 colleagues including Frank Thomas (Chairman of the Board), Sheila Finan (Control)…
Industry Colleagues
- In the Biotechnology industry, Esther Rajavelu has 35,828 colleagues in 2,404 companies located in 42 countries. 16,967 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Esther Rajavelu.
Get in Touch
Here are a few tips for establishing great contacts.
